RxDoctor Payments Data

Channa Amarasekera, MD

Urology · Huntley, ILNPI 1639596471

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $52,225 with a category attached, or 95.7%. Boston Scientific accounts for 96.4% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $50,012 and has fallen 99.6% since, to $177 in 2025. Among urology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,225in general payments, 2019–2025

Across 29 payments — averaging $1800.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$50K
  • Coloplast$2K
  • Travere Therapeutics, Inc.$150
  • Procept Biorobotics Corporation$37
  • AbbVie$29
  • 180 Medical, Inc.$23
$72,449in research payments, 2019–2025

Across 5 payments — averaging $14,490 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$62K
  • Olympus Corporation Of The Americas$11K

What the payments were for

  • Grants$50,00096%
  • Travel & lodging$1,1442%
  • Food & beverage$1,0812%

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific8$50,370
Coloplast17$1,615
Travere Therapeutics, Inc.1$150
Procept Biorobotics Corporation1$37
AbbVie1$29
180 Medical, Inc.1$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,225 in reported general payments places this provider in the 90th percentile of 550 urology providers in Illinois.

See all urology providers in Illinois

Medicare billing

Part B allowed, 2024
$213,108
Medicare patients
552
Services billed
3,215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron141$109,767
Alfuzosin Hcl ErAlfuzosin Hcl261$5,225
Testosterone27$2,845
Tamsulosin Hcl205$2,747
Silodosin32$2,487
Tadalafil37$2,097
Testosterone Cypionate34$1,725
Finasteride73$920
Ciprofloxacin Hcl20$159
Oxybutynin Chloride ErOxybutynin Chloride12$127
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim27$120
Cephalexin24$85
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$64
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$55

Paid to pharmacies, not to this prescriber.

Other urology in Huntley

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →